scott tagawa, md, on the study investigating nadofaragene firadenovec in bcg unresponsive nmibc
Published 4 years ago • 223 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
4:13
scott tagawa, md, on the prostate cancer treatment pipeline
-
26:28
radiogland therapy optimization of prostate specific membrane antigentargeted radiation
-
2:29
dr. tagawa on brca2 in patients with prostate cancer receiving psma-targeted radionuclide therapy
-
1:51
dr. tagawa on remaining questions with psma-targeted radionuclide therapy in mcrpc
-
1:24
improving the diagnosis of bladder cancer in the bladderpath study
-
15:41
nerve disorders - rife frequencies treatment - energy & quantum medicine with bioresonance
-
4:18
young heart patient receives new and improved tissue valve
-
4:21
tavr for all: 'a day that patients should celebrate'
-
4:57
botox vs. filler
-
5:49
scott tagawa, md, on the impact of racial disparity and covid-19 on prostate cancer clinical trials
-
8:52
scott tagawa, m.d. on psma pet-ct and its utility in prostate cancer - part 2
-
1:16
sculptra
-
6:02
surgeon chooses tavr
-
5:22
psma imaging: a multidisciplinary approach
-
0:38
targetable alterations in bladder cancer
-
17:41
felix 2.0: where we are, where we are going - part 1
-
2:04
unmet need in bladder cancer
-
3:56
trophy-u-01: initial findings
-
1:29:54
examining the state of the science on new therapies in bladder cancer
-
3:02
unanswered questions in psma-targeted radionuclide therapy
-
1:50
what is tavr?
-
6:42
tavi: all you need to know